218 related articles for article (PubMed ID: 26883149)
1. Identification of human telomerase inhibitors having the core of N-acyl-4,5-dihydropyrazole with anticancer effects.
Xiao X; Ni Y; Jia YM; Zheng M; Xu HF; Xu J; Liao C
Bioorg Med Chem Lett; 2016 Mar; 26(6):1508-1511. PubMed ID: 26883149
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents.
Liu XH; Ruan BF; Liu JX; Song BA; Jing LH; Li J; Yang Y; Zhu HL; Qi XB
Bioorg Med Chem Lett; 2011 May; 21(10):2916-20. PubMed ID: 21486698
[TBL] [Abstract][Full Text] [Related]
4. Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo.
Wang Y; Cheng FX; Yuan XL; Tang WJ; Shi JB; Liao CZ; Liu XH
Eur J Med Chem; 2016 Apr; 112():231-251. PubMed ID: 26900656
[TBL] [Abstract][Full Text] [Related]
5. Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.
Shi JB; Tang WJ; Qi XB; Li R; Liu XH
Eur J Med Chem; 2015 Jan; 90():889-96. PubMed ID: 25554922
[TBL] [Abstract][Full Text] [Related]
6. A novel methodology for synthesis of dihydropyrazole derivatives as potential anticancer agents.
Wang X; Pan YM; Huang XC; Mao ZY; Wang HS
Org Biomol Chem; 2014 Apr; 12(13):2028-32. PubMed ID: 24519368
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW
Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
Sun J; Zhu H; Yang ZM; Zhu HL
Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
[TBL] [Abstract][Full Text] [Related]
9. Ethenesulfonyl fluoride derivatives as telomerase inhibitors: structure-based design, SAR, and anticancer evaluation in vitro.
Chen X; Zha GF; Wang JQ; Liu XH
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1266-1270. PubMed ID: 30139286
[TBL] [Abstract][Full Text] [Related]
10. Benzophenone-nucleoside derivatives as telomerase inhibitors: Design, synthesis and anticancer evaluation in vitro and in vivo.
Shi JB; Chen LZ; Wang Y; Xiou C; Tang WJ; Zhou HP; Liu XH; Yao QZ
Eur J Med Chem; 2016 Nov; 124():729-739. PubMed ID: 27639364
[TBL] [Abstract][Full Text] [Related]
11. Novel 3-(2-(3-methyl-5-substituted-phenyl-4,5-dihydropyrazol-1-yl)-2-oxoethoxy)-2-substituted-phenyl-4H-chromen-4-one: synthesis and anticancer activity.
Liu XH; Li J; Wu FR; Song BA; Bhadury PS; Shi L
Med Chem; 2011 Nov; 7(6):605-10. PubMed ID: 22313300
[TBL] [Abstract][Full Text] [Related]
12. Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity.
Wu XQ; Huang C; Jia YM; Song BA; Li J; Liu XH
Eur J Med Chem; 2014 Mar; 74():717-25. PubMed ID: 24119869
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation, 3D-QSAR studies of novel aryl-2H-pyrazole derivatives as telomerase inhibitors.
Luo Y; Zhang S; Qiu KM; Liu ZJ; Yang YS; Fu J; Zhong WQ; Zhu HL
Bioorg Med Chem Lett; 2013 Feb; 23(4):1091-5. PubMed ID: 23312949
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents.
Huang XF; Lu X; Zhang Y; Song GQ; He QL; Li QS; Yang XH; Wei Y; Zhu HL
Bioorg Med Chem; 2012 Aug; 20(16):4895-900. PubMed ID: 22819191
[TBL] [Abstract][Full Text] [Related]
15. Novel dihydropyrazole-chromen: Design and modulates hTERT inhibition proliferation of MGC-803.
Chen YY; Wu XQ; Tang WJ; Shi JB; Li J; Liu XH
Eur J Med Chem; 2016 Mar; 110():65-75. PubMed ID: 26807545
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anticancer activity of some 8-substituted-7-methoxy-2H-chromen-2-one derivatives toward hepatocellular carcinoma HepG2 cells.
Amin KM; Abou-Seri SM; Awadallah FM; Eissa AA; Hassan GS; Abdulla MM
Eur J Med Chem; 2015 Jan; 90():221-31. PubMed ID: 25461322
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel 5-phenyl-N-piperidine ethanone containing 4,5-dihydropyrazole derivatives as potential antitumor agents.
Liu XH; Li J; Shi JB; Song BA; Qi XB
Eur J Med Chem; 2012 May; 51():294-9. PubMed ID: 22405648
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and molecular docking study of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential antitumor agents.
Liu XH; Liu HF; Chen J; Yang Y; Song BA; Bai LS; Liu JX; Zhu HL; Qi XB
Bioorg Med Chem Lett; 2010 Oct; 20(19):5705-8. PubMed ID: 20800480
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.
Zhang XM; Qiu M; Sun J; Zhang YB; Yang YS; Wang XL; Tang JF; Zhu HL
Bioorg Med Chem; 2011 Nov; 19(21):6518-24. PubMed ID: 21962523
[TBL] [Abstract][Full Text] [Related]
20. Discovery of new chromen-4-one derivatives as telomerase inhibitors through regulating expression of dyskerin.
Quan Wang J; Di Yang M; Chen X; Wang Y; Zeng Chen L; Cheng X; Hua Liu X
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1199-1211. PubMed ID: 30132373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
